Literature DB >> 7320995

Immunization and complement interaction in host defense against murine Cryptococcosis.

J R Graybill, J Ahrens.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7320995

Source DB:  PubMed          Journal:  J Reticuloendothel Soc        ISSN: 0033-6890


× No keyword cloud information.
  8 in total

1.  Cobra venom factor abrogates passive humoral resistance to syphilitic infection in hamsters.

Authors:  A A Azadegan; D R Tabor; R F Schell; J L LeFrock
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

Review 2.  Current concepts in cryptococcosis.

Authors:  T F Patterson; V T Andriole
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

3.  Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3.

Authors:  Scott Shapiro; David O Beenhouwer; Marta Feldmesser; Carlos Taborda; Michael C Carroll; Arturo Casadevall; Matthew D Scharff
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 4.  Activation of the complement system by pathogenic fungi.

Authors:  T R Kozel
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

5.  Measurement of modulation of mouse complement levels in vivo, utilizing a microtiter hemolytic assay.

Authors:  K L White; A C Anderson
Journal:  Agents Actions       Date:  1984-12

6.  Activation of the alternative complement pathway by Sporothrix schenckii.

Authors:  E N Scott; H G Muchmore; D P Fine
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

7.  Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.

Authors:  J Mukherjee; L A Pirofski; M D Scharff; A Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.

Authors:  Claudia Monari; Thomas R Kozel; Francesco Bistoni; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.